Measles and Poliomyelitis Vaccines, Immunization, and Control /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Vienna :
Springer Vienna : Imprint: Springer,
1993.
|
| Edición: | 1st ed. 1993. |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1007/978-3-7091-9278-8 |
Tabla de Contenidos:
- Editor’s introduction Measles and poliomyelitis: vaccines, immunization, and control
- I. Measles Global Control
- 1. Challenges for the global control of measles in the 1990’s
- 2. The experience with measles in the United States
- 3. Mass vaccination programme aimed at eradication of measles in Sweden
- 4. Identification of high risk groups for measles immunization
- 5. Is measles eradicable?
- 6. Safety of measles vaccines
- 7. Measles vaccines—one versus two doses: why and when
- 8. Cost-benefit analysis of a second dose measles inoculation of children
- 9. High-titer measles virus vaccines: protection evaluation
- 10. Recent approaches in the development of measles vaccines
- 11. Molecular biological basis of measles virus strain differences
- 12. Measles virus antigenic variations and the role of individual antigens in immunization
- 13. Cell-mediated immune response to measles virus
- II. Towards Poliomyelitis Eradication
- 14. Lessons from poliovirus control: strategies for eradication
- 15. Eradication of poliomyelitis: countdown or slowdown
- 16. The potential for poliovirus eradication
- 17. Poliovirus immunization situation in China
- 18. Epidemiologic and laboratory classification systems for paralytic poliomyelitis cases
- 19. Monitoring of the environment as a means of poliovirus surveillance
- 20. Criteria for the certification of poliomyelitis eradication
- 21. Poliovirus vaccine formulations
- 22. Inactivated and live attenuated poliovirus vaccines: mucosal immunity
- 23. Immunogenicity of poliovirus vaccines with special reference to the choice between oral and inactivated vaccines in developing countries
- 24. Optimal schedule for the administration of oral poliovirus vaccine
- 25. Poliovirus combined immunization with inactivated and live attenuated vaccines
- 26. Antigenicity and immunogenicity of inactivated poliovirus vaccine in combined vaccine trials
- 27. Studies aiming at improvement of inactivated poliovirus vaccine preparations
- 28. Development of candidates for new types 2 and 3 oral poliovirus recombinant vaccines
- 29. Intratypic differentiation of polioviruses
- 30. Natural evolution of oral vaccine poliovirus strains
- 31. Stability of attenuated poliovirus strain genotypes in the human intestinal tract.